XML 32 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Notes Payable
3 Months Ended
Sep. 30, 2020
Debt Disclosure [Abstract]  
Notes Payable

The Aytu BioScience Note. On February 27, 2020, the Company issued a $0.8 million promissory note (the “Note”) and received consideration of approximately $0.6 million. The Note had an eight-month term with principal and interest payable on November 1, 2020 and the recognition of approximately $0.2 million of debt discount related to the issuance of promissory notes. The discount is amortized over the life of the promissory notes through the fourth quarter of calendar 2020. During the three months ended September 30, 2020 and 2019, the Company recorded approximately $42,000 and $0, respectively, of related amortization.

 

The Innovus Notes. On January 9, 2020, prior to the completion of the merger, Innovus Pharmaceuticals, Inc. entered into a note agreement upon which it received gross proceeds of $0.4 million with a principal amount of $0.5 million. The note requires twelve equal monthly payments of approximately $45,000. As of September 30, 2020, the net balance of the note was $135,000.